BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 4211544)

  • 1. [Our preliminary experience in the field of serum prevention of anti-HDN hemolytic disease of the newborn by means of anti-D immunoglobulins].
    Arrotta U; Cardinale F; Sideri L
    Minerva Ginecol; 1972 Dec; 24(12):619-26. PubMed ID: 4211544
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problem of the dose of immunoglobulins in the prevention of hemolytic disease of newborn due to materno-fetal incompatibility of antigen D, in case of massive feto-maternal hemorrhage].
    Mattone PG; Meriggi E; De Martin G
    Minerva Ginecol; 1972 May; 24(7):337-41. PubMed ID: 4211573
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of RH-HR blood group incompatibility].
    Seyfriedowa H
    Acta Haematol Pol; 1979 Oct; 10(4):221-6. PubMed ID: 120092
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preliminary results of the use of anti-D immuno-gamma-globulin in the prevention of Rh factor isoimmunization].
    Gherardi A
    Ig Mod; 1970; 63(1):47-56. PubMed ID: 4991878
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 6. Immuno-prevention of Rh hemolytic disease of the newborn.
    McConnell RB; Woodrow JC
    Annu Rev Med; 1974; 25():165-78. PubMed ID: 4132885
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasmapheresis in Rh immunized pregnant women.
    Simonovits I; Vedrödi K; Jókuti I; Forgács J; Gy S
    Acta Haematol Pol; 1981; 12(2):65-7. PubMed ID: 6795880
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of post-partum Rh-factor isoimmunization (experience of the Hospital 1st Gynecological-Obstetrical of the Mexican Institute of Social Security)].
    Cepeda AG; Sentíes L; Fiorelli FE; Garcete JA
    Ginecol Obstet Mex; 1975 Feb; 37(220):83-91. PubMed ID: 804430
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selective Rh prevention in pregnancy].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1983; 45(3):261-74. PubMed ID: 6421025
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of gamma globulin (anti-Rh IgG) in the prevention of Rh isoimmunization].
    Rosemblit J; Rosales T; de Lima GR; Leonhardt HG; Fonseca A; Martins H
    Matern Infanc (Sao Paulo); 1971; 30(1):41-4. PubMed ID: 5002691
    [No Abstract]   [Full Text] [Related]  

  • 11. [The Kleihauer test and directed prevention of hemolytic disease of the newborn due to materno-fetal Rh-factor isoimmunization. Preventive note].
    De Luca P; Adinolfi G; Corbo M
    Minerva Ginecol; 1980 Dec; 32(12):1179-81. PubMed ID: 6793940
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-D-prevention within the scope of a regional work-community].
    Luboldt W; Lohmeyer H; Schmolling E; Hoize J; Neumann H
    Med Klin; 1970 May; 65(22):1082-8. PubMed ID: 5000118
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic measures in the prevention of Rh sensitization with anti D immunoglobulin].
    Jung K
    Dtsch Med Wochenschr; 1969 Aug; 94(33):1654-5. PubMed ID: 4183534
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of Rh isoimmunization].
    Vedra B; Smeral P
    Cesk Pediatr; 1971 Jun; 26(6):307-8. PubMed ID: 4996776
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemolytic disease of the newborn due to combination of anti-E and anti-S in the first pregnancy.
    Kanra T; Tunçer M; Pirnar A
    Turk J Pediatr; 1983; 25(1):49-54. PubMed ID: 6417855
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our preliminary experience with prevention of Rh hemolytic disease of the newborn by routine use of anti-D IgG].
    Foti A; Volpe L
    Minerva Ginecol; 1976 Jun; 28(6):502-5. PubMed ID: 828247
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunosuppressive mechanism and effect of immunoglobulins Anti D and Anti DK (IgG) in the prevention of hemolytic disease of the newborn caused by Rh incompatibility].
    Skrzypulec ZA
    Zentralbl Gynakol; 1973 Mar; 95(12):402-10. PubMed ID: 4634158
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rhesus sensitization and prevention with anti-D-immunoglobulin].
    Hindemann P; Hinselmann M; Frey P
    Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of Rh-sensitization with the use of anti-D gamma-globulin after delivery].
    Keserü TL; Kaiser G; Annus J
    Zentralbl Gynakol; 1971 Jan; 93(1):24-9. PubMed ID: 4102084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.